Nuclear Medicine and Molecular Imaging

, Volume 52, Issue 5, pp 384–388 | Cite as

Role of Positron Emission Tomography as a Biologic Marker in the Diagnosis of Primary Progressive Aphasia: Two Case Reports

  • Young Jin Jeong
  • Kyung Won Park
  • Do-Young KangEmail author
Case Report


Primary progressive aphasia (PPA) is a heterogenous neurodegenerative disorder characterized by declining language and speech ability. Various underlying neuropathologies can induce PPA, and the disorder is divided into three subtypes—progressive non-fluent aphasia, semantic variant aphasia, and logopenic aphasia—according to clinical features. Accurate disease classification and prediction of underlying diseases are necessary for appropriate treatment, but proper use of imaging tests is important because clinical information alone often makes it difficult to make accurate decisions. Because there is a characteristic metabolic pattern according to the subtypes, F-18 fluorodeoxyglucose positron emission tomography (PET) can indicate subtype classification. In addition, PET studies for imaging amyloid or dopamine transporters play an important role in demonstrating underlying disease. The present case showed that PET imaging studies are useful in diagnosis and could be used as a biomarker in PPA.


Primary progressive aphasia Positron emission tomography Fluorodeoxyglucose Amyloid Dopamine transporter Biomarker 


Compliance with Ethical Standards

Conflict of Interest

Young Jin Jeong, Kyung Won Park, and Do-Young Kang declare that they have no conflict of interest.

Ethical Approval

This article is a case report for which approval by an institutional review board is waived.

Informed Consent

Informed consent was obtained from all subjects of this case report.


  1. 1.
    Mesulam MM, Wieneke C, Thompson C, Rogalski E, Weintraub S. Quantitative classification of primary progressive aphasia at early and mild impairment stages. Brain. 2012;135:1537–53.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Vandenberghe R. Classification of the primary progressive aphasias: principles and review of progress since 2011. Alzheimers Res Ther. 2016;8:16.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006–14.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Grossman M. The non-fluent/agrammatic variant of primary progressive aphasia. Lancet Neurol. 2012;11:545–55.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Kertesz A, Harciarek M. Primary progressive aphasia. Scand J Psychol. 2014;55:191–201.CrossRefPubMedGoogle Scholar
  6. 6.
    Kirshner HS. Frontotemporal dementia and primary progressive aphasia, a review. Neuropsychiatr Dis Treat. 2014;10:1045–55.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Mesulam MM, Rogalski EJ, Wieneke C, Hurley RS, Geula C, Bigio EH, et al. Primary progressive aphasia and the evolving neurology of the language network. Nat Rev Neurol. 2014;10:554–69.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Villarejo-Galende A, Llamas-Velasco S, Gómez-Grande A, Puertas-Martín V, Contador I, Sarandeses P, et al. Amyloid pet in primary progressive aphasia: case series and systematic review of the literature. J Neurol. 2017;264:121–30.CrossRefPubMedGoogle Scholar
  9. 9.
    Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, Mormino EC, et al. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol. 2008;64:388–401.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Mesulam M, Weintraub S, Parrish T, Gitelman D. Primary progressive aphasia: reversed asymmetry of atrophy and right hemi-sphere language dominance. Neurology. 2005;64:556–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Nestor PJ, Graham NL, Fryer TD, Williams GB, Patterson K, Hodges JR. Progressive non-fluent aphasia is associated with hypometabolism centred on the left anterior insula. Brain. 2003;126:2406–18.CrossRefPubMedGoogle Scholar
  12. 12.
    Grossman M. Primary progressive aphasia: clinical-pathological correlations. Nat Rev Neurol. 2010;6:88–97.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Niccolini F, Politis M. A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism. Eur J Nucl Med Mol Imaging. 2016;43:2244–54.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Ince S, Eroglu E, Karacalioglu AO, Emer O, Alagoz E. 18F-FDG PET/CT findings in a case of a semantic variant of primary progressive aphasia. Hell J Nucl Med. 2015;18:163–5.PubMedGoogle Scholar

Copyright information

© Korean Society of Nuclear Medicine 2018

Authors and Affiliations

  1. 1.Department of Nuclear Medicine, Dong-A University College of Medicine and Medical CenterDong-A University HospitalBusanRepublic of Korea
  2. 2.Institute of Convergence Bio-HealthDong-A UniversityBusanRepublic of Korea
  3. 3.Department of Neurology, Dong-A University College of MedicineDong-A University HospitalBusanRepublic of Korea

Personalised recommendations